medline.ch Neurologie Alzheimer

	Extension of overlap measures for Multi-Class Biomarker Evaluation in Alzheimer's Disease. Sci Rep Marquina VMS, Del Carmen Pardo M, Franco-Pereira AM. PMID: 42321246 [PubMed - as supplied by publisher]
	A Comprehensive Review on the Microbial Signatures and Metabolic Mechanisms Underlying the Gut-Alzheimer's Disease Axis. Mol Neurobiol Amruthavarshini SN, Kumari N, Anand S. PMID: 42319691 [PubMed - indexed for MEDLINE]
	Different family caregiver- and care recipient-related factors are associated with the cost of care in the early, mild, and moderate stages of Alzheimer's disease in Finland: A 5-year ALSOVA study. Eur J Health Econ Jetsonen V, Välimäki T, Selander T, Kuvaja-Köllner V, Martikainen J, Koivisto AM. PMID: 42319641 [PubMed - as supplied by publisher]
	RDoC-informed explainable AI as a paradigm for multilevel Alzheimer's disease diagnosis and progression prediction: a systematic review. Brain Inform Nami M, Peebles D, Thabtah F, Kamalov F. PMID: 42319634 [PubMed - as supplied by publisher]
	RNA acetylation modification ac4C: An emerging regulatory hub of RNA metabolism disruption in Alzheimer's disease. Mol Biol Rep Xing L, Liu A, Li J, Jiang K, Li H. PMID: 42319535 [PubMed - indexed for MEDLINE]
	Digital speech-based markers to advance prognosis in Alzheimer's disease. Alzheimers Dement Lee M, Meylan S, Shobin E, SpeechDx Consortium, Nisenbaum L, Sukumar A, Kourtis L. PMID: 42318897 [PubMed - indexed for MEDLINE]
	Diagnostic performance of plasma p-Tau217, p-Tau181, and p-Tau231 across the Alzheimer's disease continuum: a network meta-analysis. Front Aging Neurosci Chen X, Huang T, Shi C, Xu S, Fan S. PMID: 42318558 [PubMed]
	Plasma lncRNA signature of upregulated ATP2B1-AS1 and downregulated RPL21P28 correlates with diagnosis and cognitive severity in Alzheimer's disease. Front Aging Neurosci Yadollahi Khales A, Ghaedi K, Esmaeili F, Noorbakhshnia M, Etemadifar M. PMID: 42318555 [PubMed]
	Heterogeneous trajectories of executive function in clinical Alzheimer's disease: Results from the 3C study. Alzheimers Dement (Amst) Amieva H, Dussartre M, Philipps V, Rouanet A, Dufouil C, Jacqmin-Gadda H, Dartigues JF, Pérès K, Samieri C, Catheline G, Helmer C, Proust-Lima C. PMID: 42318440 [PubMed]
	Ethanol exposure and high-fat diet: assessing the neuroimmune and metabolic mechanisms in Alzheimer's disease pathology. Front Neurosci Njoku GC, Saraswathi V. PMID: 42318197 [PubMed]
	Altered Effective Connectivity Within the Frontoparietal Network in Alzheimer's Disease and Its Modulation by Acupuncture: A Resting-State fMRI Study. Neuropsychiatr Dis Treat Wei YT, Li L, Xie WT, Wang Y, Zhao YR, Zhang RZ, Ma L, Yan XK. PMID: 42318047 [PubMed]
	Use of Artificial Intelligence for the Early Detection and Prediction of Alzheimer's Disease. Cureus Khangsar LT, Boileau AJ. PMID: 42317938 [PubMed]
	Nano-based spectroscopic approaches for early diagnosis of Alzheimer's disease: critical insights into amyloid-Î² and tau biomarker biology and detection tools. Biophys Rev Tatar AS, Colnita A, Brezestean IA, Boca S. PMID: 42317543 [PubMed]
	Spatial transcriptomics in Alzheimer's disease: technologies, challenges and discoveries. Mol Neurodegener Adv Shi CH, Piña-Crespo JC, Yip KY, Huang TY. PMID: 42317262 [PubMed]
	Neuropsychological criteria for Mild Cognitive Impairment (MCI) best identify neuroimaging-based risk profiles: A Department of Defense/Alzheimer's Disease Neuroimaging Initiative study. J Int Neuropsychol Soc Matchanova A, Ly MT, Frank C, Zaratan A, Bangen KJ, Bondi MW, Delano-Wood L, Department of Defense Alzheimer. PMID: 42316769 [PubMed - as supplied by publisher]
	Impact of sex differences on microglial function in Alzheimer's disease. Alzheimers Res Ther Figueiredo EV, Azevedo CV, Penitente AR, Pedrosa VR, Camilo da Silva VR, Longo BM. PMID: 42316324 [PubMed - as supplied by publisher]
	Associations of plasma biomarkers of Alzheimer's disease pathology with modifiable risk factors and cognitive and functional outcomes: evidence from cross-sectional prediction and latent path analyses in the Bio-Hermes-001 cohort. Alzheimers Res Ther Kirk M, Kwon J, Mavromati K, Gordon-Boyle A, Bhui K, Koychev I, Bauermeister S, Tsiachristas A. PMID: 42316310 [PubMed - as supplied by publisher]
	Nanoparticles that target nonamyloid and nontau pathways in Alzheimer's disease. Discov Nano Alavian F, Hajimohammadi A. PMID: 42315809 [PubMed]
	Association of Cathepsin Proteins with Alzheimer's Disease Risk: An Integrated Observational and Genetic Analysis. Neuromolecular Med Zhang Q, Li Q, Ai Z, Li F, Wang Y, Zhou W. PMID: 42315799 [PubMed - indexed for MEDLINE]
	Cannabinoids Treatment for Agitation in Alzheimer's Disease: A Systematic Review and Meta-Analysis With Bayesian and Sequential Trial Analyses. Am J Geriatr Psychiatry da Silva AMP, de Siqueira Lima DV Jr, Figueiroa Souza R, Lopes VHP, Januario Campos Cardoso L, Ornelas Pinto EL, Gonçalves OR, Braga C, Cal H, Haddad DS, Vasconcelos SMM, Duarte FS, Perry G, Anghinah R. PMID: 42315374 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 70936

Seite 1 von 3547

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung